BIND Therapeutics Information

View Top Employees from BIND Therapeutics

BIND Therapeutics is a biotechnology company incorporated in 2006; Pfizer acquired substantially all of its assets in 2016. BIND’s product candidates were based on proprietary polymeric nanoparticles called ACCURINS®, which are engineered to target specific cells and tissues in the body at sites of disease. ACCURINS®, which continue to be developed with Pfizer, have the potential to achieve therapeutic outcomes not currently possible with conventional treatment modalities.

Website	http://www.bindtherapeutics.com
Ticker	NASDAQ:BIND
Revenue	$15.4 million
Funding	$154.7 million
Employees	4 (1 on RocketReach)
Founded	2006
Address	325 Vassar Street, Cambridge, Massachusetts 02139, US
Phone	+1 617-491-3400
Fax	(617) 491-0351
Technologies	Mimecast Mailbox Continuity , The Receptionist , MATLAB +3 more (view full list)
Industry	Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Clinical Trials, Drug Manufacturing & Research, Health Care, Information Technology, Medical
Web Rank	30 Million
Keywords	Nanoparticle Drug Delivery, Targeted Drug Delivery, Targeted Therapeutics, Therapeutic Nanoparticles, Nanomedicine, Drug Delivery Systems, Precision Medicine, Nanotechnology, Biotechnology, Cancer Treatment, Innovative Therapeutics, Pharmaceutical Research, Biopharma, Drug Development, Clinical Trials, Pharmaceutical Development
Competitors	Novartis, AbbVie, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Gilead Sciences, Dendreon, Rudolph Research Analytical, Celsion Corporation +39 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 325412 Companies